79
Views
5
CrossRef citations to date
0
Altmetric
Perspective

The trials and tribulations of vitamin D: time for the ‘sunshine’ vitamin to come in out of the cold – or just more broken promises?

, &

References

  • Norman AW. The history of the discovery of vitamin D and its daughter. steroid hormone. Ann Nutr Metab 2012;61(3):199-206
  • Chesney RW. Theobald Palm and his remarkable observation: how the sunshine vitamin came to be recognized. Nutrients 2012;4(1):42-51
  • Rajakumar K, Greenspan SL, Thomas SB, Holick MF. Solar ultraviolet radiation and vitamin D: a historical perspective. Am J Public Health 2007;97(10):1746-54
  • Wolf G. The discovery of vitamin D: the contribution of Adolf Windaus. J Nutr 2004;134(6):1299-302
  • Rajakumar K. Vitamin D, cod-liver oil, sunlight, and rickets: a historical perspective. Pediatrics 2003;112(2):e132-5
  • Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011;96(7):1911-30
  • Institute of Medicine. Dietary reference intakes for calcium and vitamin D. The National Academies Press; Washington, DC: 2011
  • Heinonen OP, Albanes D. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330(15):1029-35
  • Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334(18):1150-5
  • Manson JE, Bassuk SS, Lee I, et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 2012;33(1):159-71
  • Christakos S, Ajibade DV, Dhawan P, et al. Vitamin D. Metabolism. Endocrinol Metab Clin North Am 2010;39(2):243-53
  • Holick MF. Medical progress: vitamin D deficiency. N Engl J Med 2007;357(3):266-81
  • Christakos S, Seth T, Hirsch J, et al. Vitamin D biology revealed through the study of knockout and transgenic mouse models. Annu Rev Nutr 2013;33:71-85
  • Holick MF. Vitamin D: a D-Lightful health perspective. Nutr Rev 2008;66(SUPPL.2):S182-94
  • DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004;80(6 Suppl):1689S-96S
  • Haussler MR, Jurutka PW, Mizwicki M, Norman AW. Vitamin D receptor (VDR)-mediated actions of 1a,25(OH) 2vitamin D 3: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab 2011;25(4):543-59
  • Schoindre Y, Benveniste O, Costedoat-Chalumeau N. Vitamin D and autoimmunity. Presse Med 2013;42(10):1358-63
  • Volchenkov R, Karlsen M, Jonsson R, Appel S. Type 1 regulatory T cells and regulatory B cells induced by tolerogenic dendritic cells. Scand J Immunol 2013;77(4):246-54
  • Ralph AR, Lucas RM, Norval M. Vitamin D and solar ultraviolet radiation in the risk and treatment of tuberculosis. Lancet Infect Dis 2013;13(1):77-88
  • Döring A, Paul F, Dörr J. Vitamin D and multiple sclerosis: the role for risk of disease and treatment. Nervenarzt 2013;84(2):173-89
  • Takiishi T, Van Belle T, Gysemans C, Mathieu C. Effects of vitamin D on antigen-specific and non-antigen-specific immune modulation: relevance for type 1 diabetes. Pediatr Diabetes 2013;14(2):81-9
  • Badenhoop K, Kahles H, Penna-Martinez M. Vitamin d, immune tolerance, and prevention of type 1 diabetes. Curr Diab Rep 2012;12(6):635-42
  • Mutgi K, Koo J. Update on the role of systemic vitamin D in atopic dermatitis. Pediatr Dermatol 2013;30(3):303-7
  • Tian Y, Wang C, Ye Z, et al. Effect of 1,25-Dihydroxyvitamin D3 on Th17 and Th1 response in patients with Behçet’s disease. Invest Ophthalmol Vis Sci 2012;53(10):6434-41
  • Nigwekar SU, Bhan I, Thadhani R. Ergocalciferol and cholecalciferol in CKD. Am J Kidney Dis 2012;60(1):139-56
  • Haines ST, Park SK. Vitamin D supplementation: what’s known, what to do, and what’s needed. Pharmacotherapy 2012;32(4):354-82
  • Bischoff-Ferrari HA. The 25-hydroxyvitamin D threshold for better health. J Steroid Biochem Mol Biol 2007;103(3-5):614-19
  • Bischoff-Ferrari HA. Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv Exp Med Biol 2008;624:55-71
  • Vimaleswaran KS, Berry DJ, Lu C, et al. Causal Relationship between Obesity and Vitamin D. Status: bi-Directional Mendelian Randomization Analysis of Multiple Cohorts. PLoS Med 2013;10(2):e1001383
  • Norman AW, From vitamin D to hormone D. Fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008;88(2):491S-9S
  • Carlberg C, Campbell MJ. Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids 2013;78(2):127-36
  • Binkley N, Krueger D, Cowgill CS, et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab 2004;89(7):3152-7
  • Snellman G, Melhus H, Gedeborg R, et al. Determining vitamin D status: a comparison between commercially available assays. PLoS One 2010;5:7
  • Chun RF, Peercy BE, Orwoll ES, et al. Vitamin D and DBP: the free hormone hypothesis revisited. J Steroid Biochem Mol Biol 2013. [Epub ahead of print]
  • Powe CE, Evans MK, Wenger J, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 2013;369(21):1991-2000
  • Safadi FF, Thornton P, Magiera H, et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest 1999;103(2):239-51
  • Nykjaer A, Dragun D, Walther D, et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 1999;96(4):507-15
  • Malloy PJ, Feldman D. Genetic disorders and defects in vitamin D action. Endocrinol Metab Clin North Am 2010;39(2):333-46
  • Zoccali C, Yilmaz MI, Mallamaci F. FGF23: a mature renal and cardiovascular risk factor? Blood Purif 2013;36(1):52-7
  • Quarles LD. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease. Exp Cell Res 2012;318(9):1040-8
  • Adams JS, Hewison M. Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase. Arch Biochem Biophys 2012;523(1):95-102
  • Prentice A, Goldberg GR, Schoenmakers I. Vitamin D across the lifecycle: physiology and biomarkers. Am J Clin Nutr 2008;88(2):500S-6S
  • Lamberg-Allardt CJE, Outila TA, Kärkkäinen MUM, et al. Vitamin D deficiency and bone health in healthy adults in Finland: could this be a concern in other parts of Europe? J Bone Miner Res 2001;16(11):2066-73
  • Arya V, Bhambri R, Godbole MM, Mithal A. Vitamin D status and its relationship with bone mineral density in healthy Asian Indians. Osteoporos Int 2004;15(1):56-61
  • Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged ≥60 y. Am J Clin Nutr 2004;80(3):752-8
  • De Sévaux RGL, Hoitsma AJ, Corstens FHM, Wetzels JFM. Treatment with vitamin D and calcium reduces bone loss after renal transplantation: a randomized study. J Am Soc Nephrol 2002;13(6):1608-14
  • Chapuy MC, Arlot ME, Duboeuf F, et al.Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327(23):1637-42
  • Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293(18):2257-64
  • Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009;169(6):551-61
  • Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 2013;383(9912):146-55
  • Jacques RM, Boonen S, Cosman F, et al. Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res 2012;27(8):1627-34
  • Avenell A, Gillespie WJ, Gillespie LD, O’Connell DL. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 2005(3):CD000227
  • DIPART (Vitamin D Individual Patient Analysis of Randomized Trials) Group. Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ 2010;340:b5463
  • Bischoff-Ferrari HA, Willett WC, Orav EJ, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 2012;367(1):40-9
  • Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296(23):2832-8
  • Munger KL, Zhang SM, O’Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004;62(1):60-5
  • Salzer J, Hallmans G, Nyström M, et al. Vitamin D as a protective factor in multiple sclerosis. Neurology 2012;79(21):2140-5
  • Soilu-Hänninen M, Åivo J, Lindström B-, et al. A randomised, double blind, placebo controlled trial with vitamin D 3 as an add on treatment to interferon ß-1b in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2012;83(5):565-71
  • Anderson JL, May HT, Horne BD, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010;106(7):963-8
  • Parker J, Hashmi O, Dutton D, et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 2010;65(3):225-36
  • Vacek JL, Vanga SR, Good M, et al. Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol 2012;109(3):359-63
  • Afzal S, Bojesen SE, Nordestgaard BG. Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis. Clin Chem 2013;59(2):381-91
  • Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 2011;65(9):1005-15
  • Bergman P, Lindh ÅU, Björkhem-Bergman L, Lindh JD. Vitamin D and Respiratory Tract Infections: a systematic review and nmeta-analysis of randomized controlled trials. PLoS One 2013;8(6):e65835
  • Urashima M, Segawa T, Okazaki M, et al. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010;91(5):1255-60
  • Li YC, Kong J, Wei M, et al. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002;110(2):229-38
  • Gardner DG, Chen S, Glenn DJ. Vitamin D and the heart. Am J Physiol Regul Integr Comp Physiol 2013;305(9):R969-77
  • Beveridge LA, Witham MD. Vitamin D and the cardiovascular system. Osteoporos Int 2013;24(8):2167-80
  • Pittas AG, Chung M, Trikalinos T, et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010;152(5):307-14
  • Pilz S, Kienreich K, Rutters F, et al. Role of vitamin D in the development of insulin resistance and type 2 diabetes. Curr Diab Rep 2013;13(2):261-70
  • Girgis CM, Clifton-Bligh RJ, Turner N, et al. Effects of vitamin D in skeletal muscle: falls, strength, athletic performance and insulin sensitivity. Clin Endocrinol (Oxf) 2013. [Epub ahead of print]
  • Fabri M, Stenger S, Shin D-, et al. Vitamin D is required for IFN-γ-mediated antimicrobial activity of human macrophages. Sci Transl Med 2011;3(104):p. 104ra102
  • Bolland MJ, Grey A, Gamble GD, Reid IR. Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women’s Health Initiative (WHI) limited-access data set. Am J Clin Nutr 2011;94(4):1144-9
  • Garland CF, Garland FC, Gorham ED, et al. The role of vitamin D in cancer prevention. Am J Public Health 2006;96(2):252-61
  • Garland CF, Gorham ED, Mohr SB, Garland FC. Vitamin D for cancer prevention: global perspective. Ann Epidemiol 2009;19(7):468-83
  • Grant WB. Ecological studies of the UVB-vitamin D-cancer hypothesis. Anticancer Res 2012;32(1 PART 2):223-36
  • Grant WB. Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: implications for meta-analyses and setting vitamin D guidelines. Dermatoendocrinol 2011;3(3):199-204
  • Grant WB. Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers. J Photochem Photobiol B 2010;101(2):130-6
  • Lappe JM, Travers-Gustafson D, Davies KM, et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007;85(6):1586-91
  • Moukayed M, Grant WB. Molecular link between vitamin D and cancer prevention. Nutrients 2013;5(10):3993-4021
  • Gorham ED, Garland CF, Garland FC, et al.Optimal Vitamin D. Status for Colorectal Cancer Prevention. A quantitative meta analysis. Am J Prev Med 2007;32(3):210-16
  • Gandini S, Boniol M, Haukka J, et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2011;128(6):1414-24
  • Giovannucci E. Strengths and limitations of current epidemiologic Ssudies: vitamin D as a modifier of colon and prostate cancer risk. Nutr Rev 2007;65(Suppl 2):S77-9
  • Toner CD, Davis CD, Milner JA. The Vitamin D and cancer conundrum: aiming at a moving target. J Am Diet Assoc 2010;110(10):1492-500
  • Grant WB. An estimate of the global reduction in mortality rates through doubling vitamin D levels. Eur J Clin Nutr 2011;65(9):1016-26
  • Mavroeidi A, O’Neill F, Lee PA, et al. Seasonal 25-hydroxyvitamin D changes in British postmenopausal women at 57°N and 51°N: a longitudinal study. J Steroid Biochem Mol Biol 2010;121(1-2):459-61
  • Heaney RP, Holick MF. Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 2011;26(3):455-7
  • Heaney RP. Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev 2014;72(1):48-54
  • Heaney RP. Health is better at serum 25(OH)D above 30ng/mL. J Steroid Biochem Mol Biol 2013;136:224-8
  • Holick MF. The D-batable Institute of Medicine report: a D-lightful perspective. Endocr Pract 2011;17(1):143-9
  • Holick MF. The IOM D-lemma. Public Health Nutr 2011;14(5):939-41
  • Pramyothin P, Holick MF. Vitamin D supplementation: guidelines and evidence for subclinical deficiency. Curr Opin Gastroenterol 2012;28(2):139-50
  • Jonatan Salzer. Environmental risk factors for multiple sclerosis. Umeå University, Clinical Neuroscience; Umeå, Sweden: 2013
  • Boucher BJ. The problems of vitamin d insufficiency in older people. Aging Dis 2012;3(4):313-29
  • Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 1988;67(2):373-8
  • Penny H, Frame S, Dickinson F, et al. Determinants of vitamin D status in long-term renal transplant patients. Clin Transplant 2012;26(6):E617-23
  • Springbett P, Buglass S, Young AR. Photoprotection and vitamin D status. J Photochem Photobiol B 2010;101(2):160-8
  • Davies PSW, Bates CJ, Cole TJ, et al. Vitamin D: seasonal and regional differences in preschool children in Great Britain. Eur J Clin Nutr 1999;53(3):195-8
  • Ovesen L, Andersen R, Jakobsen J. Geographical differences in vitamin D status, with particular reference to European countries. Proc Nutr Soc 2003;62(4):813-21
  • Hart PH, Gorman S. Exposure to UV wavelengths in sunlight suppresses immunity. To what extent is UV-induced vitamin D3 the mediator responsible? Clin Biochem Rev 2013;34(1):3-13
  • Sayre RM, Dowdy JC. Darkness at noon: sunscreens and vitamin D3. Photochem Photobiol 2007;83(2):459-63
  • Sollitto RB, Kraemer KH, DiGiovanna JJ. Normal vitamin D levels can be maintained despite rigorous photoprotection: six years’ experience with xeroderma pigmentosum. J Am Acad Dermatol 1997;37(6):942-7
  • Holvik K, Meyer HE, Haug E, Brunvand L. Prevalence and predictors of vitamin D deficiency in five immigrant groups living in Oslo, Norway: the Oslo immigrant health study. Eur J Clin Nutr 2005;59(1):57-63
  • Shaw NJ, Pal BR. Vitamin D deficiency in UK Asian families: activating a new concern. Arch Dis Child 2002;86(3):147-9
  • Awumey EM, Mitra DA, Hollis BW, et al. Vitamin D metabolism is altered in Asian Indians in the southern United States: a clinical research center study. J Clin Endocrinol Metab 1998;83(1):169-73
  • Ørnsrud R, Lock EJ, Glover CN, Flik G. Retinoic acid cross-talk with calcitriol activity in Atlantic salmon (Salmo salar). J Endocrinol 2009;202(3):473-82
  • Reichrath J, Lehmann B, Carlberg C, et al. Vitamins as hormones. Horm Metab Res 2007;39(2):71-84
  • Cross SF, Dalla Pozza L, Munns CF. Hypercalcemia and osteoblastic lesions induced by 13-cis-retinoic acid mimicking relapsed neuroblastoma. Pediatr Blood Cancer 2009;53(4):666-8
  • Mugishima H, Chin M, Suga M, et al. Hypercalcemia induced by 13 cis-retinoic acid in patients with neuroblastoma. Pediatr Int 2008;50(2):235-7
  • Conaway HH, Henning P, Lerner UH. Vitamin a metabolism, action, and role in skeletal homeostasis. Endocr Rev 2013;34(6):766-97
  • Whiting SJ, Calvo MS. Correcting poor vitamin D status: do older adults need higher repletion doses of vitamin D3 than younger adults? Mol Nutr Food Res 2010;54(8):1077-84
  • Jacobus CH, Holick MF, Shao Q, et al. Hypervitaminosis D associated with drinking milk. N Engl J Med 1992;326(18):1173-7
  • Masterjohn C. Vitamin D toxicity redefined: vitamin K and the molecular mechanism. Med Hypotheses 2007;68(5):1026-34
  • Vieth R. Vitamin D toxicity, policy, and science. J Bone Miner Res 2007;22(Suppl 2):V64-8
  • Kallas M, Green F, Hewison M, et al. Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review. J Clin Endocrinol Metab 2010;95(7):3111-17
  • Favus MJ. editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 2nd edition. Raven Press; NY: USA: 1993
  • Barbour GL, Coburn JW, Slatopolsky E, et al. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin d. N Engl J Med 1981;305(8):440-3
  • Feldman D, Pike JW, Glorieux FH. editors. In: Vitamin D. 2nd edition). Elsevier; San Diego, CA, USA: 2005
  • Engelsen O. The relationship between ultraviolet radiation exposure and vitamin D status. Nutrients 2010;2(5):482-95
  • Dobson R, Giovannoni G, Ramagopalan S. The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude. J Neurol Neurosurg Psychiatry 2013;84(4):427-32
  • Farrar MD, Kift R, Felton SJ, et al. Recommended summer sunlight exposure amounts fail to produce sufficient vitamin D status in UK adults of South Asian origin. Am J Clin Nutr 2011;94(5):1219-24
  • Alvarez JA, Wasse H, Tangpricha V. Vitamin D supplementation in pre-dialysis chronic kidney disease: a systematic review. Dermatoendocrinol 2012;4(2):118-27
  • Schmid A, Walther B. Natural vitamin D content in animal products. Adv Nutr 2013;4(4):453-62
  • Björn LO, Wang T. Vitamin D in an ecological context. Int J Circumpolar Health 2000;59(1):26-32
  • Madsen KH, Rasmussen LB, Andersen R, et al. Randomized controlled trial of the effects of vitamin D-fortified milk and bread on serum 25-hydroxyvitamin D concentrations in families in Denmark during winter: the VitmaD study. Am J Clin Nutr 2013;98(2):374-82
  • Burgaz A, Åkesson A, Öster A, et al. Associations of diet, supplement use, and ultraviolet B radiation exposure with vitamin D status in Swedish women during winter. Am J Clin Nutr 2007;86(5):1399-404
  • Brustad M, Alsaker E, Engelsen O, et al. Vitamin D status of middle-aged women at 65-71°N in relation to dietary intake and exposure to ultraviolet radiation. Public Health Nutr 2004;7(2):327-35
  • Vieth R, Chan P-R, MacFarlane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001;73(2):288-94
  • Hathcock JN, Shao A, Vieth R, Heaney R. Risk assessment for vitamin D. Am J Clin Nutr 2007;85(1):6-18
  • Gravesen E, Hofman-Bang J, Lewin E, Olgaard K. Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 4-5. Scand J Clin Lab Invest 2013;73(2):107-16
  • Reichrath J, Reichrath S. The relevance of the vitamin D endocrine system (VDES) for tumorigenesis, prevention, and treatment of non-melanoma skin cancer (NMSC): present concepts and future perspectives. Dermatoendocrinol 2013;5(1):38-50
  • Ala-Houhala MJ, Karppinen T, Vähävihu K, et al. Narrow-band ultraviolet B treatment boosts serum 25-hydroxyvitamin D in patients with psoriasis on oral vitamin D supplementation. Acta Derm Venereol 2014;94(2):146-51
  • Ala-Houhala MJ, Vähävihu K, Hasan T, et al. Narrow-band ultraviolet B exposure increases serum vitamin D levels in haemodialysis patients. Nephrol Dial Transplant 2012;27(6):2435-40
  • Ala-Houhala MJ, Vähävihu K, Hasan T, et al. Comparison of narrowband ultraviolet B exposure and oral vitamin D substitution on serum 25-hydroxyvitamin D concentration. Br J Dermatol 2012;167(1):160-4
  • Ala-Houhala MJ, Vähävihu K, Snellman E, et al. A narrow-band ultraviolet B course improves vitamin D balance and alters cutaneous CYP27A1 and CYP27B1 mRNA expression levels in haemodialysis patients supplemented with oral vitamin D. Nephron Clin Pract 2013;124(1-2):17-22
  • Terra VA, Souza-Neto FP, Pereira RC, et al. Nitric oxide is responsible for oxidative skin injury and modulation of cell proliferation after 24 hours of UVB exposures. Free Radic Res 2012;46(7):872-82
  • Clemens TL, Adams JS, Henderson SL, Holick MF. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 1982;1(8263):74-6
  • Bacon CJ, Gamble GD, Horne AM, et al. High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int 2009;20(8):1407-15
  • Heaney RP. Vitamin D--baseline status and effective dose. N Engl J Med 2012;367(1):77-8
  • Hollis BW. Assessment and interpretation of circulating 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in the clinical environment. Endocrinol Metab Clin North Am 2010;39(2):271-86
  • Khosla S. What do we tell our patients about calcium and vitamin D supplementation? J Clin Endocrinol Metab 2011;96(1):69-71
  • VITAL. Available from: www.vitalstudy.org
  • clinicaltrials.gov (NCT01169259). Available from: clinicaltrials.gov/show/NCT01169259
  • Palinski W, Napoli C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. FASEB J 2002;16(11):1348-60
  • Grant WB. Critique of the U-shaped serum 25-hydroxyvitamin D level-disease response relation. Dermatoendocrinol 2009;1(6):289-93
  • Lappe JM, Heaney RP. Why randomized controlled trials of calcium and vitamin D sometimes fail. Dermatoendocrinol 2012;4(2):95-100
  • Maxmen A. The vitamin D-lemma. Nature 2011;475(7354):23-5
  • Battault S, Whiting SJ, Peltier SL, et al. Vitamin D metabolism, functions and needs: from science to health claims. Eur J Nutr 2013;52(2):429-41
  • Bailey BA, Manning T, Peiris AN. Vitamin D testing patterns among six Veterans Medical Centers in the Southeastern United States: links with medical costs. Mil Med 2012;177(1):70-6
  • Vitamin D assessment (ViDA) study. Available from: www.fmhs.auckland.ac.nz/soph/depts/epi/vida/
  • Pludowski P, Holick MF, Pilz S, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev 2013;12(10):976-89
  • Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diab Endo 2014;2(1):76-89
  • Bolland MJ, Grey A, Gamble GD, Reid IR. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diab Endo 2014. [Epub ahead of print]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.